Cybin (HELP) Operating Expenses (2020 - 2026)
Cybin (HELP) posted quarterly Operating Expenses of $47.9 million for Q1 2026, down 51.99% year-on-year from $99.7 million in Q1 2025, and up 16.13% on a QoQ basis from $41.2 million in Q4 2025.
Cybin (HELP) Operating Expenses (2020 - 2026) Analysis & Trends
Cybin (HELP) has reported Operating Expenses for 7 consecutive years, with $47.9 million the latest figure, recorded in Q1 2026.
- Quarterly Operating Expenses fell 51.99% year-over-year to $47.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $142.6 million (down 13.48% YoY) and the FY2026 annual result came in at $142.6 million, up 38.27% from the prior year.
- Operating Expenses climbed to $47.9 million in Q1 2026 per HELP's latest filing, from $41.2 million in the prior quarter.
- Over the last five years, Operating Expenses for HELP reached as high as $99.7 million in Q1 2025 and fell as low as -$16.9 million in Q1 2023.
- A 5-year average of $21.9 million and a median of $9.5 million in 2023 frame the typical range for Operating Expenses.
- Annual changes were most pronounced in 2022 — Operating Expenses sank 99.91% — and 2024, when it soared 411479.04%.
- Year by year, Operating Expenses stood at $8.9 million in 2022, then sank by 99.78% to $19850.1 in 2023, then jumped by 112685.39% to $22.4 million in 2024, then soared by 84.07% to $41.2 million in 2025, then grew by 16.13% to $47.9 million in 2026.
- According to Business Quant data, Operating Expenses over the past three periods registered $47.9 million, $41.2 million, and $28.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -28.01 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.10 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.78 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.85 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.96 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 32.68 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 2.89 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 445.22 Mn |
| 10 | Cybin | 28.04 Mn | 28.04 Mn | - | 47.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 47.86 Mn |
| Dec 31, 2025 | 41.21 Mn |
| Sep 30, 2025 | 28.89 Mn |
| Jun 30, 2025 | 24.62 Mn |
| Mar 31, 2025 | 99.68 Mn |
| Dec 31, 2024 | 22.39 Mn |
| Sep 30, 2024 | 42.71 Mn |
| Jun 30, 2024 | 20,317.00 |
| Mar 31, 2024 | 58.47 Mn |
| Dec 31, 2023 | 19,850.09 |
| Sep 30, 2023 | 10,375.89 |
| Jun 30, 2023 | 9.46 Mn |
| Feb 28, 2023 | -16.88 Mn |
| Dec 31, 2022 | 8.91 Mn |
| Sep 30, 2022 | 12,327.00 |
| May 31, 2022 | 4.55 Mn |
| Mar 31, 2022 | 16,338.00 |
| Dec 31, 2021 | 16,455.00 |
| Sep 30, 2021 | 13.59 Mn |
| Jun 30, 2021 | 11,339.76 |